Mustang Bio Inc

NASDAQ: MBIO
$0.26
+$0.01 (+2.8%)
Closing Price on November 8, 2024

MBIO Stock Chart and Intraday Price

MBIO Stock Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, US
Fiscal Year End December
Latest Quarter 2023-12-31
Market Cap 8.16M USD
Shares Outstanding 9,544,800
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.

MBIO Articles

5 Buy-Rated Stocks Trading Below $10 With Outstanding Upside Potential
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
Lee Jackson
Published: